ASTS
AST SpaceMobile, Inc.
ASTS has the edge over CTM overall, supported by stronger fundamentals and stronger modeled upside.
CTM
Castellum, Inc.
CTM has lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CTM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Weak |
CTM's revenue and cash flow are currently stable, but its profitability and balance sheet are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CTM PE Valuation
CTM has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CTM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect CTM's earnings to decline, with its revenue and profitability holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.04 | +$0.02 |
| Q2 2026 | -$0.03 | +$0.05 |
| Q1 2026 | -$0.02 | +$0.09 |
| Q4 2025 | -$0.03 | +$0.15 |
| Q3 2025 | -$0.06 | +$0.12 |
| Q2 2025 | -$0.08 | +$0.27 |
| Q1 2025 | -$0.11 | +$0.25 |
| Q4 2024 | -$0.18 | +$0.20 |
CTM has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CTM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.7M | +0.6% |
| Q2 2026 | $13.9M | -1.1% |
| Q1 2026 | $14.3M | +23% |
| Q4 2025 | $12.6M | +22% |
| Q3 2025 | $14.6M | +26% |
| Q2 2025 | $14M | +22% |
| Q1 2025 | $11.7M | +2.9% |
| Q4 2024 | $10.3M | -7.1% |
CTM's revenue is growing: $15M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.8% | -6.9 points |
| Q2 2026 | -7.9% | -5.2 points |
| Q1 2026 | -4.9% | +7.9 points |
| Q4 2025 | -11% | +4.7 points |
| Q3 2025 | 3% | +15 points |
| Q2 2025 | -2.7% | +11 points |
| Q1 2025 | -13% | +11 points |
| Q4 2024 | -16% | -1.9 points |
CTM has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.3M | -234% |
| Q1 2026 | $1.3M | +$3.8M |
| Q4 2025 | -$671.5K | -$277.1K |
| Q3 2025 | $957K | +30% |
| Q1 2025 | -$2.5M | -10647% |
| Q4 2024 | -$394.4K | -145% |
| Q3 2024 | $738.9K | +$2M |
| Q2 2024 | $748.6K | +33% |
CTM has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +138K shares |
| 1 year | +5.6% | +5.1M shares |
| 3 years | +96% | +46.5M shares |
| 5 years | +515% | +79.4M shares |
| Available history | +543% | +80.1M shares |
CTM has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CTM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 29.1x | High |
| Q1 2021 | 11.1x | High |
CTM's net debt is more than 20 years of its operating earnings (EBITDA).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 14.3 | Oversold |
CTM's weekly RSI is 36 (neutral) and its Stochastic is 14 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CTM PE vs Technology Sector
CTM has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over CTM on trend strength, trading above more of its moving averages.
CTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.54 | 17% below |
| 20 week MA | $0.60 | 25% below |
| 50 week MA | $0.74 | 39% below |
| 100 week MA | $0.91 | 51% below |
| 200 week MA | $0.67 | 33% below |
CTM is in a downtrend: it's below all five of its weekly moving averages, and 33% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over CTM on returns for 2026, with the stronger performance.
CTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $1.47 | $1.22 | -17% |
| 2023 | $1.22 | $0.30 | -75% |
| 2024 | $0.30 | $1.42 | +373% |
| 2025 | $1.42 | $1.03 | -27% |
| 2026 YTD | $1.03 | $0.45 | -56% |
CTM's yearly returns have swung widely, from +373% in 2024 to −75% in 2023. It's down 56% so far in 2026.